These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of asthma with antileukotrienes: first line or last resort therapy? Dahlén SE Eur J Pharmacol; 2006 Mar; 533(1-3):40-56. PubMed ID: 16510137 [TBL] [Abstract][Full Text] [Related]
3. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. Claesson HE; Dahlén SE J Intern Med; 1999 Mar; 245(3):205-27. PubMed ID: 10205583 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of asthma. Palmer LJ; Silverman ES; Weiss ST; Drazen JM Am J Respir Crit Care Med; 2002 Apr; 165(7):861-6. PubMed ID: 11934710 [No Abstract] [Full Text] [Related]
5. 5-Lipoxygenase: a target for antiinflammatory drugs revisited. Steinhilber D Curr Med Chem; 1999 Jan; 6(1):71-85. PubMed ID: 9873115 [TBL] [Abstract][Full Text] [Related]
6. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction. Hendeles L Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782 [No Abstract] [Full Text] [Related]
7. [The role of leukotrienes in inflammation and leukotriene inhibitors]. Kupczyk M; Kuna P Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480 [TBL] [Abstract][Full Text] [Related]
8. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma. Devillier P; Baccard N; Advenier C Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma. Drazen JM Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785 [TBL] [Abstract][Full Text] [Related]
11. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment]. Fal AM; Kopeć A Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521 [TBL] [Abstract][Full Text] [Related]
12. Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma. Larsen JS; Acosta EP Ann Pharmacother; 1993; 27(7-8):898-903. PubMed ID: 8364276 [TBL] [Abstract][Full Text] [Related]
13. Treatment of asthma with drugs modifying the leukotriene pathway. Drazen JM; Israel E; O'Byrne PM N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400 [No Abstract] [Full Text] [Related]
14. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma. Devillier P; Baccard N; Advenier C Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986 [TBL] [Abstract][Full Text] [Related]
15. The potential role of antileukotriene drugs in atherosclerosis. Spanbroek R; Habenicht AJ Drug News Perspect; 2003 Oct; 16(8):485-9. PubMed ID: 14668944 [TBL] [Abstract][Full Text] [Related]
16. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors]. Diamant Z; Sterk PJ Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053 [TBL] [Abstract][Full Text] [Related]
17. Treatment of aspirin-intolerant asthma with antileukotrienes. Dahlén B Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S137-41. PubMed ID: 10673243 [No Abstract] [Full Text] [Related]
18. 5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents. Jampilek J; Dolezal M; Opletalova V; Hartl J Curr Med Chem; 2006; 13(2):117-29. PubMed ID: 16472209 [TBL] [Abstract][Full Text] [Related]
19. Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis. Mirshafiey A; Jadidi-Niaragh F Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):219-27. PubMed ID: 20298145 [TBL] [Abstract][Full Text] [Related]
20. The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma. Sorkness CA Pharmacotherapy; 1997; 17(1 Pt 2):50S-54S. PubMed ID: 9017788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]